Skip to main content
HHS Logo U.S. Department of Health & Human Services NIH logo National Institutes of Health

Discovering New Therapeutic Uses for Existing Molecules

Crystal McKnight examines a compound source plate.
NCATS Funding Available to Repurpose Existing Drugs

Interested in identifying new treatments for a broad range of diseases using partially developed therapeutic candidates? Access two new funding opportunities.

Doctor with child patient
NCATS Funds Drug Repurposing Projects, Seeks New Industry Partners

NCATS is seeking additional industry partners to participate in future New Therapeutic Uses funding opportunities.

Work with Us

Learn more about how you can access funding and collaborate with the New Therapeutic Uses program.

Bobbie Ann Mount, Ph.D.

New Therapeutic Uses Facts

Therapeutic development is a costly, complex and time consuming process. The average length of time from target discovery to approval of a new drug is about 14 years. The failure rate during this process exceeds 95 percent, and the cost per successful drug can be $1 billion or more. The high therapeutic development failure rate means there are many existing, partially developed therapeutic candidates that could be repurposed for use in new disease indications.Learn more about the New Therapeutic Uses program through the fact sheet (PDF - 395KB).